IDP2Biomed
aims to integrate IDP-related information with biomedical data, advance the understanding of the function of IDPs in normal and disease states and explore new avenues to alter their behaviour in pathological states.
The IDP2Biomed twinning program is aimed at strengthening the scientific excellence and innovation
capacity at the interface between Chemistry and Biology of the Faculty of Science of Eötvös Loránd
University (ELTE). Researchers from ELTE will be working closely together with three leading European
research groups in the field of intrinsically disordered proteins (IDPs). This partnership will provide
an ideal platform to enable ELTE to increase its ability to generate scientific innovation and clinical
translation. This objective will be achieved by focusing on IDPs that are directly involved in diseases
with great socio-economic importance, such as neurodegenerative diseases and rare diseases.
